These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15639074)

  • 1. Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen.
    Anderson FD; Hait H; Hsiu J; Thompson-Graves AL; Wilborn WH; Williams RF
    Contraception; 2005 Jan; 71(1):55-9. PubMed ID: 15639074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo.
    Anderson FD; Feldman R; Reape KZ
    Contraception; 2008 Feb; 77(2):91-6. PubMed ID: 18226671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol.
    Anderson FD; Gibbons W; Portman D
    Contraception; 2006 Mar; 73(3):229-34. PubMed ID: 16472561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial.
    Anderson FD; Gibbons W; Portman D
    Am J Obstet Gynecol; 2006 Jul; 195(1):92-6. PubMed ID: 16813747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval.
    Sulak P; Willis S; Kuehl T; Coffee A; Clark J
    Headache; 2007 Jan; 47(1):27-37. PubMed ID: 17355491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring performance during the menstrual cycle: a model using oral contraceptives.
    Redman LM; Weatherby RP
    Med Sci Sports Exerc; 2004 Jan; 36(1):130-6. PubMed ID: 14707778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the pharmacokinetic profile of an ascending-dose, extended-regimen combined oral contraceptive to those of other extended regimens.
    Darwish M; Bond M; Ricciotti N; Hsieh J; Fiedler-Kelly J; Grasela T
    Reprod Sci; 2014 Nov; 21(11):1401-10. PubMed ID: 24647707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.
    Coffee AL; Sulak PJ; Kuehl TJ
    Contraception; 2007 Jun; 75(6):444-9. PubMed ID: 17519150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Light and electron microscopy changes in the endometrium caused by the administration of a norgestimate-containing oral contraceptive (Cilest)].
    Rabe T; Leppien G; Kiesel L; Runnebaum B; Heinrich D; Johannisson E; Ludwig H
    Geburtshilfe Frauenheilkd; 1986 Dec; 46(12):883-91. PubMed ID: 3817409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
    Sänger N; Stahlberg S; Manthey T; Mittmann K; Mellinger U; Lange E; Kuhl H; Wiegratz I
    Contraception; 2008 Jun; 77(6):420-5. PubMed ID: 18477491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
    Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
    Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen.
    Coffee AL; Kuehl TJ; Willis S; Sulak PJ
    Am J Obstet Gynecol; 2006 Nov; 195(5):1311-9. PubMed ID: 16796986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 micro g/ethinyl estradiol 20 micro g.
    Johnson JV; Grubb GS; Constantine GD
    Contraception; 2007 Jan; 75(1):23-6. PubMed ID: 17161119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.
    Kaunitz AM; Portman DJ; Hait H; Reape KZ
    Contraception; 2009 May; 79(5):350-5. PubMed ID: 19341846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, safety and sustainability of treatment continuation and results of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg chlormadinone acetate, in long-term usage (up to 45 cycles)--an open-label, prospective, noncontrolled, office-based Phase III study.
    Zahradnik HP; Hanjalic-Beck A
    Contraception; 2008 May; 77(5):337-43. PubMed ID: 18402849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days.
    Foidart JM; Sulak PJ; Schellschmidt I; Zimmermann D;
    Contraception; 2006 Jan; 73(1):34-40. PubMed ID: 16371292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estrogens. Contraceptive therapy].
    Sojo-Aranda I; Cortés-Gallegos V
    Ginecol Obstet Mex; 1995 Jan; 63():46-9. PubMed ID: 7896159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.